Structural and Biochemical Characterization of the Francisella tularensis Pathogenicity Regulator, Macrophage Locus

Bonnie J Cuthbert1, Richard G Brennan1, Maria A Schumacher1

  • 1Department of Biochemistry, Duke University School of Medicine, Durham, North Carolina, 27710, United States of America.

Plos One
|June 30, 2015
PubMed

Insights

Francisella tularensis virulence depends on the MglA and SspA proteins regulating gene transcription. MglA uniquely forms dimers and binds malate, potentially influencing its function in bacterial pathogenesis.

Area of Science:

  • Microbiology
  • Structural Biology
  • Bacterial Pathogenesis

Background:

  • Francisella tularensis causes tularemia and its virulence is linked to the Francisella Pathogenicity Island (FPI).
  • MglA and SspA regulate FPI transcription by interacting with RNA polymerase and PigR.
  • Unlike other bacteria, F. tularensis SspA forms a heterodimer with MglA, a unique interaction.

Purpose of the Study:

  • To elucidate the molecular mechanisms of MglA function in Francisella tularensis.
  • To investigate the structural and biochemical properties of MglA.
  • To understand how MglA interacts with SspA and regulates FPI transcription.

Main Methods:

  • X-ray crystallography was used to determine the structure of MglA.
  • Biochemical assays including chemical crosslinking and size exclusion chromatography (SEC) were performed.
  • Structural analysis focused on MglA's fold, dimerization, and potential ligand-binding sites.

Main Results:

  • MglA shares structural similarity with the SspA protein family.
  • MglA can form homodimers in crystals and in solution, but preferentially heterodimerizes with SspA.
  • A malate molecule was found bound in a pocket formed by the MglA dimer, suggesting a ligand-binding role.

Conclusions:

  • MglA's unique heterodimerization with SspA is crucial for F. tularensis virulence.
  • The identified malate-binding site in MglA may play a role in regulating FPI transcription.
  • Further research into small molecule binding could reveal new therapeutic targets for tularemia.